Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on june 30, 2025 that were previously approved by the compensation committee of its board of directors under sarepta's 2024 employment commencement incentive plan, as a material inducement to employment to 53 individuals hired by sarepta in the second quarter of 2025. the equity awards were approved in accordance with nasdaq listing rule.
SRPT Ratings Summary
SRPT Quant Ranking